Capsular polysaccharide synthesis

Capsular polysaccharide synthesis refers to the multi-step, enzyme-catalyzed assembly and export of high-molecular-weight polysaccharides that form the capsule, a surface structure of many pathogenic bacteria. The capsule is a well-organized, often serotype-specific polysaccharide layer lying outside the cell envelope. It serves as a major virulence factor, protecting bacteria from host immune defenses such as phagocytosis and complement-mediated killing. There are several conserved biosynthetic mechanisms, including the Wzy-dependent pathway, ATP-binding cassette (ABC) transporter-dependent pathway, and synthase-dependent pathways, all involving various glycosyltransferases, polymerases, and transporters[1][3][5][7]. Because the capsule is antigenic, its polysaccharide components are used as vaccine targets, although molecule inhibition of the capsule biosynthetic machinery for direct therapy is primarily at the research stage[4][5]. Capsule synthesis systems are considered potential drug targets due to their essential role in bacterial pathogenesis and lack of direct homologs in humans. Capsule-specific inhibitors and vaccines are under investigation or in clinical use for several medically important pathogens.

Other names

Capsule biosynthesisCPS biosynthesisCapsule formation

For vaccines: Induce immune response to capsular polysaccharide antigens, promoting opsonization and bacterial clearance. For enzyme-targeted drugs: Inhibition of essential enzymes in capsule biosynthesis prevents capsule formation, reducing virulence and increasing susceptibility to immune clearance[5].